What Are Precancerous Skin Lesions?

Precancerous skin lesions are abnormal growths on the skin that have the potential to develop into skin cancer if left untreated. Ameluz® is a specialized pharmaceutical product designed for the photodynamic therapy (PDT) treatment of these lesions. It offers a targeted and effective solution for individuals seeking to manage and potentially prevent the progression of precancerous skin conditions.

How Does It Work?

Ameluz® contains a photosensitizing agent called aminolevulinic acid (ALA). When applied topically to the affected area, Ameluz® is absorbed by the abnormal cells in the lesion. When exposed to a specific wavelength of light, these cells become highly sensitive and are selectively destroyed, leaving healthy skin tissue unaffected.

Product Highlights

  • Targeted Treatment: Ameluz® is specifically formulated to target and treat precancerous skin lesions, providing a focused approach to managing these potentially dangerous growths.

  • Minimally Invasive: The treatment involves the topical application of Ameluz® and subsequent light exposure, making it a minimally invasive alternative to surgical procedures for precancerous lesions.

  • Clinically Proven: Ameluz® has been clinically tested and demonstrated efficacy in the treatment of precancerous skin lesions, providing a well-established solution for individuals seeking to address these conditions.

Indications

Ameluz® is indicated for the treatment of mild to moderate actinic keratosis (AK), a common type of precancerous skin lesion caused by sun exposure.